Paul Panipinto researches rheumatology, a branch of medicine which focuses on the management of inflammation in the bones, joints, and internal organs. After receiving his bachelor’s from the University of […]
By Judith Van Dongen, WSU Health Sciences Spokane Office of Research SPOKANE, Wash. – Scientists have identified a protein known as sulfatase‑2 that plays a critical role in the damage […]
On August 12, current and future scientists gathered to show off their work at the College of Pharmacy and Pharmaceutical Sciences (CPPS) Research Day. The all-day event is a celebration […]
Looking for a change after completing his undergraduate degree in chemistry, Chris Szlenk left his home state of Alabama in 2017 to pursue a PhD at Washington State University’s College of Pharmacy and Pharmaceutical Sciences. A rotation in the lab of assistant professor Senthil Natesan got him interested in the field of computer-aided drug design.
Using cannabis alongside other drugs may come with a significant risk of harmful drug-drug interactions, new research by scientists at Washington State University suggests.
The researchers looked at cannabinoids—a group of substances found in the cannabis plant—and their major metabolites found in cannabis users’ blood and found that they interfere with two families of enzymes that help metabolize a wide range of drugs prescribed for a variety of conditions. As a result, either the drugs’ positive effects might decrease or their negative effects might increase with too much building up in the body, causing unintended side effects such as toxicity or accidental overdose.
WSU College of Pharmacy and Pharmaceutical Sciences alumna, Dr. Sara Dumit, was invited to attend the 70th Lindau Nobel Laureate Meeting this past summer, which convenes in Lindau, Germany. This annual meeting gives the next generation of leading scientists in the world the chance to discuss global issues ranging from climate change to genome editing with Nobel Laureates. She is among the leading theorists working on the modeling of plutonium decorporation and the development of chelation models. These models help to better understand the movement of plutonium inside the human body during chelation therapy, otherwise known as the process of binding to heavy metals which is then removed from the body.
When the class of 2021 first began their Pharmaceutical Sciences and Molecular Medicine and Doctor of Pharmacy journeys, no one could have imagined how it would end—there was no global pandemic on the horizon and it was beyond imagination that their final year would be spent any differently than those of their predecessors.
During commencement week, the WSU College of Pharmacy and Pharmaceutical Sciences (CPPS) celebrated all that the class of 2021 has accomplished over the past year and the course of their graduate education.
As COVID-19 spread across the globe, colleges found themselves pivoting to distance learning experiences leaving students, faculty and staff to adapt to a rapidly changing environment while navigating the implications of a global pandemic. Though everyone in the college deserves to be recognized for persevering through this difficult year, several have been recognized by their peers for their outstanding leadership, teamwork and service.
Pharmacy Roles in Pharmaceutical Industry Most PharmD students know that their degree can land them a career in the pharmaceutical industry, but what exactly do people with a PharmD degree […]
By Addy Hatch, WSU News When Shamema Nasrin and her husband moved from Bangladesh to Spokane to attend the WSU College of Pharmacy and Pharmaceutical Sciences, they didn’t know how to […]